InvestorsHub Logo
Followers 91
Posts 5592
Boards Moderated 0
Alias Born 06/05/2008

Re: None

Monday, 02/13/2017 4:14:54 PM

Monday, February 13, 2017 4:14:54 PM

Post# of 8169
Important new CLRB analytic report:

https://finance.yahoo.com/news/cellectar-biosciences-pdc-delivery-platform-205418085.html


I particularly like this last part:

The peer-reviewed data in both reports was consistent in several conclusions, but one clearly stands out to benefit Cellectar: both journals provided insight, review and validation of the unique potential and varied utility of its PDC platform. With this validation comes the increased likelihood of partnership and licensing opportunities as the company continues to mature the pipeline.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLRB News